Researchers compare blood test methods for haemophilia b drug monitoring
NCT ID NCT04590950
First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 32 times
Summary
This study looked at 15 people with severe haemophilia B who were taking a medicine called eftrenonacog-alfa (a recombinant factor IX). The goal was to see how well different lab tests measure the level of clotting factor in their blood. Researchers also checked how the medicine works in everyday life. The study did not test a new treatment, but aimed to improve how doctors monitor the effects of this therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE HAEMOPHILIA B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service d'hématologie biologique - Hôpital Cochin
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.